Profile
Daniel Getts is the founder of Cour Pharmaceuticals Development Co., Inc.,CREATE Medicines, Inc. (Massachusetts).
Dr. Getts is currently Director at Curate Biosciences since 2022.
Formerly, Dr. Getts was Director-Research & Development at Tolera Therapeutics, Inc. and Vice President-Research at TCR² Therapeutics, Inc. from 2017 to 2019.
Dr. Getts earned a doctorate from Northwestern University and both a graduate degree and a doctorate from The University of Sydney.
Daniel Getts active positions
| Companies | Position | Start |
|---|---|---|
Myeloid Therapeutics, Inc.
Myeloid Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic drugs for the treatment of tumors and autoimmune diseases | Founder | - |
Curate Biosciences
Curate Biosciences Miscellaneous Commercial ServicesCommercial Services Provides medical research and cell separation services | Director/Board Member | 2022-08-14 |
Former positions of Daniel Getts
| Companies | Position | End |
|---|---|---|
| TCR2 THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 2019-02-28 |
Cour Pharmaceuticals Development Co., Inc.
Cour Pharmaceuticals Development Co., Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes biopharmaceuticals to treat autoimmune diseases | Founder | - |
Tolera Therapeutics, Inc.
Tolera Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel therapies and technologies for immune modulation | Corporate Officer/Principal | - |
Training of Daniel Getts
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Sydney
The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tolera Therapeutics, Inc.
Tolera Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel therapies and technologies for immune modulation | Commercial Services |
Curate Biosciences
Curate Biosciences Miscellaneous Commercial ServicesCommercial Services Provides medical research and cell separation services | Commercial Services |
Cour Pharmaceuticals Development Co., Inc.
Cour Pharmaceuticals Development Co., Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes biopharmaceuticals to treat autoimmune diseases | Health Technology |
TCR2 Therapeutics, Inc.
TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage cell therapy company which engages in the development of biological drugs and engineering T-cells for cancer therapy | Health Technology |
Myeloid Therapeutics, Inc.
Myeloid Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic drugs for the treatment of tumors and autoimmune diseases | Health Technology |
- Stock Market
- Insiders
- Daniel Getts
















